✦ LIBER ✦

624 Absence of effect of pegylated interferon alpha-2b on the pharmacokinetics of valopicitabine (NM283) in patients with chronic hepatitis C

✍ Scribed by X.J. Zhou; B. Fielman; G. Chao; S. Knox; N. Brown

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of chronic hepatitis C in HIV

✍ A. Cargnel; E. Angeli; A. Mainini; A. Casella; G. Gubertini; R. Giorgi; G. Orlan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Population pharmacokinetic analysis of p

✍ Jen, J 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 176 KB

The effect of alpha - 2b - interferon on

✍ S. Kanatakis; C. Petrogiannopoulos; D. Koutsis; A. Agelou; A. Zaharof; A. Moussi 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Effect of therapy with interferon-alpha

✍ M. Homoncik; W. Jessner; W. Sieghardt; A. Gangl; P. Ferenci; M. Peck-Radosavljev 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

PEGylated interferon alpha 2B induces le

✍ Yashma Patel; Rajeev Chapalamadugu; Susan Ramdhaney; Robin Baradarian; Kadirawel 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 54 KB

PIN53 Cost-Effectiveness Analysis of Peg

✍ T. Macioch; J. Paweska; M. Niewada; H. Berak; M. Szkultecka-Debek; M. Russel-Szy 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB